AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7943829 — intervention group
Group type: COMPARATOR
Intervention: placebo (saline)
Number of subjects: 256
Study 2878741 — intervention group
Group type: EXPERIMENTAL
Intervention: pindolol
Number of subjects: 30
Study 2878741 — intervention group
Group type: EXPERIMENTAL
Intervention: propranolol
Number of subjects: 30
Study 2878741 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol
Number of subjects: 30
Study 2878741 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 30
Study 2878741 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 31895722 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide and manometry-assisted biofeedback exercises
Number of subjects: 296
Study 31895722 — intervention group
Group type: COMPARATOR
Intervention: Placebo and educational pamphlet
Number of subjects: 296
Study 29634425 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 108
Study 29634425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 26431470 — intervention group
Group type: EXPERIMENTAL
Intervention: AFN-1252 200 mg single dose in fed versus fasted subjects
Number of subjects: 0
Study 26431470 — intervention group
Group type: EXPERIMENTAL
Intervention: AFN-1252 200, 300, and 400 mg doses administered once-daily for 10 days
Number of subjects: 0
Study 26431470 — intervention group
Group type: EXPERIMENTAL
Intervention: AFN-1252 (all doses)
Number of subjects: 0
Study 24992845 — intervention group
Group type: EXPERIMENTAL
Intervention: PerioGlas (particulate form)
Number of subjects: 28
Study 24992845 — intervention group
Group type: COMPARATOR
Intervention: NovaBone Dental Putty (putty form)
Number of subjects: 28
Study 23732254 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated curtains (ITCs)
Number of subjects: 0
Study 23732254 — intervention group
Group type: COMPARATOR
Intervention: Non-treated curtains (NTCs)
Number of subjects: 0
Study 20804678 — intervention group
Group type: EXPERIMENTAL
Intervention: Melanoscan comprehensive cutaneous photography system
Number of subjects: 53
Study 18199693 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab (group D)
Number of subjects: 109
Study 18199693 — intervention group
Group type: COMPARATOR
Intervention: Thymoglobulin (group T)
Number of subjects: 109
Study 18199693 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab (group D) without chemoprophylaxis
Number of subjects: 109
Study 18199693 — intervention group
Group type: COMPARATOR
Intervention: Thymoglobulin (group T) without chemoprophylaxis
Number of subjects: 109
Study 16430413 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine gel (0.2 mg.kg(‐1), 1 mg.ml(‐1))
Number of subjects: 120
Study 16430413 — intervention group
Group type: COMPARATOR
Intervention: Morphine solution in saline (0.2 mg.kg(‐1), 1 mg.ml(‐1))
Number of subjects: 120
Study 12975069 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 84
Study 12975069 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 84
Study 11107681 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb‐IIIa receptor inhibitors
Number of subjects: 0
Study 8602715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol reduction
Number of subjects: 0
Study 8602715 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening with total cholesterol levels
Number of subjects: 0
Study 1327177 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein diet (Group A)
Number of subjects: 35
Study 1327177 — intervention group
Group type: COMPARATOR
Intervention: Special diet for patients with intolerance to glucose (Group B)
Number of subjects: 35
Study 1327177 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 35
Study 3862608 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) - 600 mg/day
Number of subjects: 12
Study 3862608 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambroxol (AMB) - 90 mg/day
Number of subjects: 12
Study 3862608 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30894192 — intervention group
Group type: EXPERIMENTAL
Intervention: Steepest gradients-based training (N = 7)
Number of subjects: 16
Study 30894192 — intervention group
Group type: COMPARATOR
Intervention: Standard 'centre-out' reaching training (N = 9)
Number of subjects: 16
Study 29210916 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-intensity exercise (70% peak power output)
Number of subjects: 20
Study 29210916 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (40% peak power output)
Number of subjects: 20
Study 29210916 — intervention group
Group type: COMPARATOR
Intervention: Control (rest)
Number of subjects: 20
Study 26774901 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular autologous PRP injection
Number of subjects: 30
Study 26774901 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PRP injection)
Number of subjects: 30
Study 25126978 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineal protection device
Number of subjects: 1148
Study 25126978 — intervention group
Group type: COMPARATOR
Intervention: Control group (no device)
Number of subjects: 1148
Study 20056436 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (1 μg/kg bolus followed by a 0.5 μg/kg/min infusion for 30 minutes after induction but before sternotomy)
Number of subjects: 40
Study 20056436 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 40
Study 19001213 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser-created flaps
Number of subjects: 43
Study 19001213 — intervention group
Group type: COMPARATOR
Intervention: Mechanical keratome-created flaps
Number of subjects: 43
Study 15975980 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired associative stimulation (PAS) applied to the common peroneal nerve during the swing phase of walking
Number of subjects: 14
Study 12846706 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation induction with sevoflurane
Number of subjects: 100
Study 12846706 — intervention group
Group type: COMPARATOR
Intervention: Intravenous induction with thiopental
Number of subjects: 100
Study 11764112 — intervention group
Group type: EXPERIMENTAL
Intervention: 32% phosphoric acid etching
Number of subjects: 30
Study 11764112 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonding system and fiber posts
Number of subjects: 30
Study 11764112 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 2) - SEM examination without further treatment
Number of subjects: 30
Study 8804878 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetorphan (100-300 mg thrice daily)
Number of subjects: 13
Study 8804878 — intervention group
Group type: COMPARATOR
Intervention: Octreotide (50-150 micrograms thrice daily)
Number of subjects: 13
Study 1299252 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-treated resin composite inlay (7.5 minutes at 125 degrees C)
Number of subjects: 60
Study 1299252 — intervention group
Group type: COMPARATOR
Intervention: Non-heat-treated resin composite inlay
Number of subjects: 60
Study 1299252 — intervention group
Group type: EXPERIMENTAL
Intervention: All restorations (heat-treated and non-heat-treated)
Number of subjects: 60
Study 6698743 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical imipramine 0.05%
Number of subjects: 27
Study 6698743 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 27
Study 30654777 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive website for people at familial risk for depression
Number of subjects: 202
Study 30654777 — intervention group
Group type: COMPARATOR
Intervention: Control website
Number of subjects: 202
Study 30193579 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic subcutaneous scopolaminebutyl
Number of subjects: 200
Study 30193579 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 26765472 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath Series 3 videolaryngoscope
Number of subjects: 180
Study 25458333 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM)
Number of subjects: 40
Study 25458333 — intervention group
Group type: COMPARATOR
Intervention: Internet-based blood glucose monitoring (IBGM)
Number of subjects: 40
Study 22129855 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc- and micronutrient-rich food supplementation
Number of subjects: 180
Study 22129855 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayurvedic zinc (Jasad) tablets
Number of subjects: 180
Study 22129855 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 180
Study 19766734 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselor initiated tobacco quit line with 6 scheduled telephone sessions and 8 weeks of nicotine replacement therapy (NRT)
Number of subjects: 950
Study 19766734 — intervention group
Group type: COMPARATOR
Intervention: Participant initiated tobacco quit line with 6 scheduled telephone sessions and 2 weeks of nicotine replacement therapy (NRT)
Number of subjects: 950
Study 17344030 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypericum extract (W55570) 300 mg t.i.d
Number of subjects: 375
Study 17344030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 375
Study 16779058 — intervention group
Group type: EXPERIMENTAL
Intervention: McMaster PLUS interface 1
Number of subjects: 200
Study 16779058 — intervention group
Group type: COMPARATOR
Intervention: McMaster PLUS interface 2
Number of subjects: 200
Study 11862898 — intervention group
Group type: EXPERIMENTAL
Intervention: Lingual nerve protection during germectomies
Number of subjects: 300
Study 11862898 — intervention group
Group type: COMPARATOR
Intervention: No lingual nerve protection during germectomies
Number of subjects: 300
Study 9574879 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (FPANS) 200 microg, once daily for 7 days
Number of subjects: 28
Study 9574879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 7812088 — intervention group
Group type: EXPERIMENTAL
Intervention: Titrated trabeculectomy technique (tight scleral flap, 10/0 nylon sutures, argon laser lysis)
Number of subjects: 128
Study 7812088 — intervention group
Group type: COMPARATOR
Intervention: Traditional trabeculectomy technique
Number of subjects: 128
Study 2958047 — intervention group
Group type: EXPERIMENTAL
Intervention: 123I hippuran
Number of subjects: 0
Study 2958047 — intervention group
Group type: COMPARATOR
Intervention: 131I hippuran
Number of subjects: 0
Study 31973615 — intervention group
Group type: EXPERIMENTAL
Intervention: Food supplementation with nutraceuticals (vitamins, oligo-minerals, plant extracts, essential amino- and fatty acids)
Number of subjects: 0
Study 30055591 — intervention group
Group type: EXPERIMENTAL
Intervention: Care and treatment services for PLHIV
Number of subjects: 671
Study 26856228 — intervention group
Group type: EXPERIMENTAL
Intervention: Culprit lesion only percutaneous coronary intervention (PCI) with possible staged non-culprit lesion revascularization
Number of subjects: 706
Study 26856228 — intervention group
Group type: COMPARATOR
Intervention: Immediate multivessel PCI
Number of subjects: 706
Study 26856228 — intervention group
Group type: EXPERIMENTAL
Intervention: Culprit lesion only PCI
Number of subjects: 706
Study 23945035 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month resistance training intervention
Number of subjects: 56
Study 23945035 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study 23911247 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic endovascular aortic repair (TEVAR)
Number of subjects: 60784
Study 23911247 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower SES
Number of subjects: 60784
Study 23911247 — intervention group
Group type: COMPARATOR
Intervention: Open thoracic aortic repair
Number of subjects: 60784
Study 20434864 — intervention group
Group type: EXPERIMENTAL
Intervention: HAHA program (integrated health education and exercise program)
Number of subjects: 40
Study 20434864 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 40
Study 18363894 — intervention group
Group type: EXPERIMENTAL
Intervention: MMX mesalazine 2.4 g/day
Number of subjects: 517
Study 18363894 — intervention group
Group type: EXPERIMENTAL
Intervention: MMX mesalazine 4.8 g/day
Number of subjects: 517
Study 18363894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 517
Study 16423144 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (50 mg)
Number of subjects: 26
Study 16423144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 12915252 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-Hz electrical acupoint stimulation (EAS)
Number of subjects: 0
Study 12915252 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-Hz electrical acupoint stimulation (EAS)
Number of subjects: 0
Study 10702430 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (4 ppm)
Number of subjects: 68
Study 10702430 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandin E(1) infusion (8 ng/kg/min)
Number of subjects: 68
Study 9116784 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed circulating-water blanket
Number of subjects: 76
Study 9116784 — intervention group
Group type: COMPARATOR
Intervention: Warmed convective-air blanket
Number of subjects: 76
Study 7682395 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermo-chemotherapy (Group B)
Number of subjects: 21
Study 7682395 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (Group A)
Number of subjects: 21
Study 6135690 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam (mean daily dose: 59 mg)
Number of subjects: 114
Study 6135690 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (mean daily dose: 25 mg)
Number of subjects: 114
Study 6135690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 31481581 — intervention group
Group type: EXPERIMENTAL
Intervention: BRAFV600 mutated patients (35 patients, 100 lesions)
Number of subjects: 70
Study 31481581 — intervention group
Group type: COMPARATOR
Intervention: BRAF wild-type patients (35 patients, 79 lesions)
Number of subjects: 70
Study 29303067 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified tumescent solution (gas‐liquid mixing tumescent solution)
Number of subjects: 186
Study 29303067 — intervention group
Group type: COMPARATOR
Intervention: Traditional tumescent solution
Number of subjects: 186
Study 26394161 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8mg
Number of subjects: 14
Study 26394161 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide
Number of subjects: 14
Study 24518770 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured withdrawal of desmopressin
Number of subjects: 259
Study 24518770 — intervention group
Group type: COMPARATOR
Intervention: Direct withdrawal of desmopressin
Number of subjects: 259
Study 24518770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study 22246690 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting with aggressive medical management
Number of subjects: 0
Study 22246690 — intervention group
Group type: COMPARATOR
Intervention: Aggressive medical management
Number of subjects: 0
Study 19338702 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent management training
Number of subjects: 238
Study 16376417 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin (C)
Number of subjects: 0
Study 16376417 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus paclitaxel (CP)
Number of subjects: 0
Study 15191101 — intervention group
Group type: EXPERIMENTAL
Intervention: Protamin
Number of subjects: 100
Study 15191101 — intervention group
Group type: COMPARATOR
Intervention: Control (sheath removal after 3 hours)
Number of subjects: 100
Study 15191101 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study 15191101 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 10815703 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer-type dementia (AD) patients
Number of subjects: 10
Study 10815703 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal controls
Number of subjects: 10
Study 10815703 — intervention group
Group type: COMPARATOR
Intervention: Semantic dementia (SD) patients
Number of subjects: 10
Study 9010687 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg digoxin
Number of subjects: 8
Study 9010687 — intervention group
Group type: COMPARATOR
Intervention: Digitaloid mixtures (equivalent amount to digoxin)
Number of subjects: 8
Study 6686810 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejunal reinfusion of aspirated duodenal fluid
Number of subjects: 0
Study 6686810 — intervention group
Group type: COMPARATOR
Intervention: No jejunal reinfusion of aspirated duodenal fluid (control)
Number of subjects: 0
Study 31058652 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxegol
Number of subjects: 276
Study 31058652 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG 3350
Number of subjects: 276
Study 31058652 — intervention group
Group type: COMPARATOR
Intervention: Naloxegol and PEG 3350
Number of subjects: 276
Study 28962668 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering/discontinuation of antipsychotic medication using a smartphone application to monitor early warning signs of psychotic relapse
Number of subjects: 250
Study 28962668 — intervention group
Group type: COMPARATOR
Intervention: Maintenance therapy with antipsychotic medication
Number of subjects: 250
Study 28962668 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering/discontinuation of antipsychotic medication
Number of subjects: 250
Study 28962668 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering/discontinuation and maintenance therapy
Number of subjects: 250
Study 25251548 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 23
Study 23530608 — intervention group
Group type: EXPERIMENTAL
Intervention: Education only
Number of subjects: 100
Study 23530608 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and mailed sunscreen
Number of subjects: 100
Study 23530608 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and text message reminders
Number of subjects: 100
Study 23530608 — intervention group
Group type: EXPERIMENTAL
Intervention: Education, mailed sunscreen, and text message reminders
Number of subjects: 100
Study 20804524 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse specialists providing care for patients with UI
Number of subjects: 6
Study 18543484 — intervention group
Group type: EXPERIMENTAL
Intervention: Airening Suppository (ARN)
Number of subjects: 54
Study 18543484 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin suppository
Number of subjects: 54
Study 16641323 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) adjunctive therapy at a target dose of 60 mg/kg/day
Number of subjects: 198
Study 16641323 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) adjunctive therapy
Number of subjects: 198
Study 16641323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study 14584069 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocaloric low-fat/high-fiber diet (20% calories as fat, 25 g/day fiber, at least 8 servings of fruits/vegetables per day)
Number of subjects: 213
Study 14584069 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (control group)
Number of subjects: 213
Study 14584069 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocaloric low-fat/high-fiber diet
Number of subjects: 213
Study 11054631 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate stent implantation
Number of subjects: 100
Study 11054631 — intervention group
Group type: COMPARATOR
Intervention: Standard techniques (prolonged dilatation or emergency bypass surgery)
Number of subjects: 100
Study 8840371 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine myocardial perfusion imaging
Number of subjects: 0
Study 1740678 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM‐CSF (5 days at every other cycle, dosages of 2, 4, 8, and 16 micrograms/kg)
Number of subjects: 24
Study 1740678 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM‐CSF (5 days at every other cycle)
Number of subjects: 24
Study 1740678 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM‐CSF (8 and 16 micrograms/kg)
Number of subjects: 24
Study 1740678 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM‐CSF (subcutaneous or intravenous administration)
Number of subjects: 24
Study 1740678 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM‐CSF
Number of subjects: 24
Study 6342130 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole and tobramycin
Number of subjects: 97
Study 6342130 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole alone (placebo for tobramycin)
Number of subjects: 97
Study 31784702 — intervention group
Group type: EXPERIMENTAL
Intervention: topical tacrolimus 0.1%
Number of subjects: 49
Study 31784702 — intervention group
Group type: COMPARATOR
Intervention: topical cyclosporine 1%
Number of subjects: 49
Study 30642687 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood sexual abuse (CSA) in women
Number of subjects: 444
Study 30642687 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood sexual abuse (CSA) in men
Number of subjects: 444
Study 30642687 — intervention group
Group type: COMPARATOR
Intervention: Childhood physical abuse
Number of subjects: 444
Study 30642687 — intervention group
Group type: EXPERIMENTAL
Intervention: Needs for care
Number of subjects: 444
Study 28411246 — intervention group
Group type: EXPERIMENTAL
Intervention: GDF‐15 measured at 1 month after ACS (elevated GDF‐15 >1800 ng/L)
Number of subjects: 4049
Study 28411246 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GDF‐15 levels (elevated) followed by nonelevated GDF‐15 at 1 month
Number of subjects: 4049
Study 27254652 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (1Hz, 20min, 20 sessions)
Number of subjects: 12
Study 27254652 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 12
Study 24388594 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary nutritional care
Number of subjects: 82
Study 22230187 — intervention group
Group type: EXPERIMENTAL
Intervention: Part C early intervention (EI) therapy
Number of subjects: 128